https://www.selleckchem.com/B-Raf.html
19, P = 0.019), women (β coeff -0.18, P 0.001), patients of age ≥ 45 years (β coeff -0.18, P 0.001), patients with body mass index ≥ 35 kg/m2 (β coeff -0.17, P 0.001), and patients with diabetes (β coeff -0.18, P = 0.02. Among women, the protective effect of HSD17B131 rs72613567 A-allele on risk of steatohepatitis was stronger in those aged ≥ 51 years. Logistic regression-based sensitivity analysis including various important subgroups confirmed our observations. The protection conferred by HSD17B13 rs72613567 A-allele on risk of
Like
Comment
Share
